Blood Pressure Disorders Drug Market Report

Global and Region Blood Pressure Disorders Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：164
  • REPORT CODE：GMM993128
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Blood Pressure Disorders Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Blood Pressure Disorders Drugmarket, defines the market attractiveness level of Blood Pressure Disorders Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Blood Pressure Disorders Drug industry, describes the types of Blood Pressure Disorders Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Blood Pressure Disorders Drug market and the development prospects and opportunities of Blood Pressure Disorders Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Blood Pressure Disorders Drug market in Chapter 13.

    By Player:

    • Celsion Corp

    • Celtaxsys Inc

    • Ascendia Pharmaceuticals LLC

    • Anavex Life Sciences Corp

    • Bayer AG

    • Ache Laboratorios Farmaceuticos SA

    • Boryung Pharmaceutical Co Ltd

    • Chiesi Farmaceutici SpA

    • Biolab Farmaceutica Ltda

    • Actelion Pharmaceuticals Ltd

    • Corion Biotech Srl

    • Biogen Inc

    • AnGes Inc

    • Aerogen Ltd

    • Bial - Portela & Ca SA

    • Arena Pharmaceuticals Inc

    • Complexa Inc

    • Bioblue Technologies Inc

    • Camurus AB

    • Chugai Pharmaceutical Co Ltd

    • A1M Pharma AB

    • Capricor Therapeutics Inc

    • Ascendis Pharma A/S

    • CJ HealthCare Corp

    • AVEO Pharmaceuticals Inc

    • Bristol-Myers Squibb Co

    • BioRestorative Therapies Inc

    • Acceleron Pharma Inc

    • Chong Kun Dang Pharmaceutical Corp

    By Type:

    • Diuretics

    • Angiotensin Converting Enzyme (ACE) Inhibitors

    • Angiotensin Receptor Blockers (ARBs)

    • Others

    By End-User:

    • Hypertension

    • Hypotension

    • Pulmonary Hypertension

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Blood Pressure Disorders Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Blood Pressure Disorders Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Blood Pressure Disorders Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Blood Pressure Disorders Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Blood Pressure Disorders Drug Market Analysis and Outlook to 2022

    • 7.1 Global Blood Pressure Disorders Drug Consumption (2017-2022)

    • 7.2 United States Blood Pressure Disorders Drug Consumption (2017-2022)

    • 7.3 Europe Blood Pressure Disorders Drug Consumption (2017-2022)

    • 7.4 China Blood Pressure Disorders Drug Consumption (2017-2022)

    • 7.5 Japan Blood Pressure Disorders Drug Consumption (2017-2022)

    • 7.6 India Blood Pressure Disorders Drug Consumption (2017-2022)

    • 7.7 South Korea Blood Pressure Disorders Drug Consumption (2017-2022)

    8 Region and Country-wise Blood Pressure Disorders Drug Market Analysis and Outlook to 2028

    • 8.1 Global Blood Pressure Disorders Drug Consumption Forecast (2022-2028)

    • 8.2 United States Blood Pressure Disorders Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Blood Pressure Disorders Drug Consumption Forecast (2022-2028)

    • 8.4 China Blood Pressure Disorders Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Blood Pressure Disorders Drug Consumption Forecast (2022-2028)

    • 8.6 India Blood Pressure Disorders Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Blood Pressure Disorders Drug Consumption Forecast (2022-2028)

    9 Global Blood Pressure Disorders Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Blood Pressure Disorders Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Diuretics Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Angiotensin Receptor Blockers (ARBs) Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Blood Pressure Disorders Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hypertension Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hypotension Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Pulmonary Hypertension Consumption and Growth Rate (2017-2022)

    10 Global Blood Pressure Disorders Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Blood Pressure Disorders Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Diuretics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Angiotensin Receptor Blockers (ARBs) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Blood Pressure Disorders Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hypertension Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hypotension Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Pulmonary Hypertension Consumption Forecast and Growth Rate (2022-2028)

    11 Global Blood Pressure Disorders Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Blood Pressure Disorders Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Blood Pressure Disorders Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Blood Pressure Disorders Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Blood Pressure Disorders Drug Market Competitive Analysis

    • 14.1 Celsion Corp

      • 14.1.1 Celsion Corp Company Details

      • 14.1.2 Celsion Corp Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Celsion Corp Blood Pressure Disorders Drug Product and Service

    • 14.2 Celtaxsys Inc

      • 14.2.1 Celtaxsys Inc Company Details

      • 14.2.2 Celtaxsys Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Celtaxsys Inc Blood Pressure Disorders Drug Product and Service

    • 14.3 Ascendia Pharmaceuticals LLC

      • 14.3.1 Ascendia Pharmaceuticals LLC Company Details

      • 14.3.2 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Product and Service

    • 14.4 Anavex Life Sciences Corp

      • 14.4.1 Anavex Life Sciences Corp Company Details

      • 14.4.2 Anavex Life Sciences Corp Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Anavex Life Sciences Corp Blood Pressure Disorders Drug Product and Service

    • 14.5 Bayer AG

      • 14.5.1 Bayer AG Company Details

      • 14.5.2 Bayer AG Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bayer AG Blood Pressure Disorders Drug Product and Service

    • 14.6 Ache Laboratorios Farmaceuticos SA

      • 14.6.1 Ache Laboratorios Farmaceuticos SA Company Details

      • 14.6.2 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Product and Service

    • 14.7 Boryung Pharmaceutical Co Ltd

      • 14.7.1 Boryung Pharmaceutical Co Ltd Company Details

      • 14.7.2 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product and Service

    • 14.8 Chiesi Farmaceutici SpA

      • 14.8.1 Chiesi Farmaceutici SpA Company Details

      • 14.8.2 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Product and Service

    • 14.9 Biolab Farmaceutica Ltda

      • 14.9.1 Biolab Farmaceutica Ltda Company Details

      • 14.9.2 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Product and Service

    • 14.10 Actelion Pharmaceuticals Ltd

      • 14.10.1 Actelion Pharmaceuticals Ltd Company Details

      • 14.10.2 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Product and Service

    • 14.11 Corion Biotech Srl

      • 14.11.1 Corion Biotech Srl Company Details

      • 14.11.2 Corion Biotech Srl Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Corion Biotech Srl Blood Pressure Disorders Drug Product and Service

    • 14.12 Biogen Inc

      • 14.12.1 Biogen Inc Company Details

      • 14.12.2 Biogen Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Biogen Inc Blood Pressure Disorders Drug Product and Service

    • 14.13 AnGes Inc

      • 14.13.1 AnGes Inc Company Details

      • 14.13.2 AnGes Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 AnGes Inc Blood Pressure Disorders Drug Product and Service

    • 14.14 Aerogen Ltd

      • 14.14.1 Aerogen Ltd Company Details

      • 14.14.2 Aerogen Ltd Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Aerogen Ltd Blood Pressure Disorders Drug Product and Service

    • 14.15 Bial - Portela & Ca SA

      • 14.15.1 Bial - Portela & Ca SA Company Details

      • 14.15.2 Bial - Portela & Ca SA Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Bial - Portela & Ca SA Blood Pressure Disorders Drug Product and Service

    • 14.16 Arena Pharmaceuticals Inc

      • 14.16.1 Arena Pharmaceuticals Inc Company Details

      • 14.16.2 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Product and Service

    • 14.17 Complexa Inc

      • 14.17.1 Complexa Inc Company Details

      • 14.17.2 Complexa Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Complexa Inc Blood Pressure Disorders Drug Product and Service

    • 14.18 Bioblue Technologies Inc

      • 14.18.1 Bioblue Technologies Inc Company Details

      • 14.18.2 Bioblue Technologies Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Bioblue Technologies Inc Blood Pressure Disorders Drug Product and Service

    • 14.19 Camurus AB

      • 14.19.1 Camurus AB Company Details

      • 14.19.2 Camurus AB Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Camurus AB Blood Pressure Disorders Drug Product and Service

    • 14.20 Chugai Pharmaceutical Co Ltd

      • 14.20.1 Chugai Pharmaceutical Co Ltd Company Details

      • 14.20.2 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product and Service

    • 14.21 A1M Pharma AB

      • 14.21.1 A1M Pharma AB Company Details

      • 14.21.2 A1M Pharma AB Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 A1M Pharma AB Blood Pressure Disorders Drug Product and Service

    • 14.22 Capricor Therapeutics Inc

      • 14.22.1 Capricor Therapeutics Inc Company Details

      • 14.22.2 Capricor Therapeutics Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Capricor Therapeutics Inc Blood Pressure Disorders Drug Product and Service

    • 14.23 Ascendis Pharma A/S

      • 14.23.1 Ascendis Pharma A/S Company Details

      • 14.23.2 Ascendis Pharma A/S Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 Ascendis Pharma A/S Blood Pressure Disorders Drug Product and Service

    • 14.24 CJ HealthCare Corp

      • 14.24.1 CJ HealthCare Corp Company Details

      • 14.24.2 CJ HealthCare Corp Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.24.3 CJ HealthCare Corp Blood Pressure Disorders Drug Product and Service

    • 14.25 AVEO Pharmaceuticals Inc

      • 14.25.1 AVEO Pharmaceuticals Inc Company Details

      • 14.25.2 AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.25.3 AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Product and Service

    • 14.26 Bristol-Myers Squibb Co

      • 14.26.1 Bristol-Myers Squibb Co Company Details

      • 14.26.2 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.26.3 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Product and Service

    • 14.27 BioRestorative Therapies Inc

      • 14.27.1 BioRestorative Therapies Inc Company Details

      • 14.27.2 BioRestorative Therapies Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.27.3 BioRestorative Therapies Inc Blood Pressure Disorders Drug Product and Service

    • 14.28 Acceleron Pharma Inc

      • 14.28.1 Acceleron Pharma Inc Company Details

      • 14.28.2 Acceleron Pharma Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.28.3 Acceleron Pharma Inc Blood Pressure Disorders Drug Product and Service

    • 14.29 Chong Kun Dang Pharmaceutical Corp

      • 14.29.1 Chong Kun Dang Pharmaceutical Corp Company Details

      • 14.29.2 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.29.3 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Blood Pressure Disorders Drug

    • Figure Blood Pressure Disorders Drug Picture

    • Table Global Blood Pressure Disorders Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Blood Pressure Disorders Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Blood Pressure Disorders Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Blood Pressure Disorders Drug Consumption by Country (2017-2022)

    • Figure United States Blood Pressure Disorders Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Blood Pressure Disorders Drug Consumption and Growth Rate (2017-2022)

    • Figure China Blood Pressure Disorders Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Blood Pressure Disorders Drug Consumption and Growth Rate (2017-2022)

    • Figure India Blood Pressure Disorders Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Blood Pressure Disorders Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Pressure Disorders Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Blood Pressure Disorders Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Blood Pressure Disorders Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Blood Pressure Disorders Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Blood Pressure Disorders Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Blood Pressure Disorders Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Blood Pressure Disorders Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diuretics Consumption and Growth Rate (2017-2022)

    • Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Angiotensin Receptor Blockers (ARBs) Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hypertension Consumption and Growth Rate (2017-2022)

    • Figure Global Hypotension Consumption and Growth Rate (2017-2022)

    • Figure Global Pulmonary Hypertension Consumption and Growth Rate (2017-2022)

    • Figure Global Diuretics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Angiotensin Receptor Blockers (ARBs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hypertension Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hypotension Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pulmonary Hypertension Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Blood Pressure Disorders Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Blood Pressure Disorders Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Celsion Corp (Foundation Year, Company Profile and etc.)

    • Table Celsion Corp Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celsion Corp Blood Pressure Disorders Drug Product and Service

    • Table Celtaxsys Inc (Foundation Year, Company Profile and etc.)

    • Table Celtaxsys Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celtaxsys Inc Blood Pressure Disorders Drug Product and Service

    • Table Ascendia Pharmaceuticals LLC (Foundation Year, Company Profile and etc.)

    • Table Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Product and Service

    • Table Anavex Life Sciences Corp (Foundation Year, Company Profile and etc.)

    • Table Anavex Life Sciences Corp Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Anavex Life Sciences Corp Blood Pressure Disorders Drug Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Blood Pressure Disorders Drug Product and Service

    • Table Ache Laboratorios Farmaceuticos SA (Foundation Year, Company Profile and etc.)

    • Table Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Product and Service

    • Table Boryung Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product and Service

    • Table Chiesi Farmaceutici SpA (Foundation Year, Company Profile and etc.)

    • Table Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Product and Service

    • Table Biolab Farmaceutica Ltda (Foundation Year, Company Profile and etc.)

    • Table Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Product and Service

    • Table Actelion Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)

    • Table Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Product and Service

    • Table Corion Biotech Srl (Foundation Year, Company Profile and etc.)

    • Table Corion Biotech Srl Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Corion Biotech Srl Blood Pressure Disorders Drug Product and Service

    • Table Biogen Inc (Foundation Year, Company Profile and etc.)

    • Table Biogen Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Inc Blood Pressure Disorders Drug Product and Service

    • Table AnGes Inc (Foundation Year, Company Profile and etc.)

    • Table AnGes Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table AnGes Inc Blood Pressure Disorders Drug Product and Service

    • Table Aerogen Ltd (Foundation Year, Company Profile and etc.)

    • Table Aerogen Ltd Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aerogen Ltd Blood Pressure Disorders Drug Product and Service

    • Table Bial - Portela & Ca SA (Foundation Year, Company Profile and etc.)

    • Table Bial - Portela & Ca SA Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bial - Portela & Ca SA Blood Pressure Disorders Drug Product and Service

    • Table Arena Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Product and Service

    • Table Complexa Inc (Foundation Year, Company Profile and etc.)

    • Table Complexa Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Complexa Inc Blood Pressure Disorders Drug Product and Service

    • Table Bioblue Technologies Inc (Foundation Year, Company Profile and etc.)

    • Table Bioblue Technologies Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bioblue Technologies Inc Blood Pressure Disorders Drug Product and Service

    • Table Camurus AB (Foundation Year, Company Profile and etc.)

    • Table Camurus AB Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Camurus AB Blood Pressure Disorders Drug Product and Service

    • Table Chugai Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product and Service

    • Table A1M Pharma AB (Foundation Year, Company Profile and etc.)

    • Table A1M Pharma AB Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table A1M Pharma AB Blood Pressure Disorders Drug Product and Service

    • Table Capricor Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Capricor Therapeutics Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Capricor Therapeutics Inc Blood Pressure Disorders Drug Product and Service

    • Table Ascendis Pharma A/S (Foundation Year, Company Profile and etc.)

    • Table Ascendis Pharma A/S Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ascendis Pharma A/S Blood Pressure Disorders Drug Product and Service

    • Table CJ HealthCare Corp (Foundation Year, Company Profile and etc.)

    • Table CJ HealthCare Corp Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table CJ HealthCare Corp Blood Pressure Disorders Drug Product and Service

    • Table AVEO Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Product and Service

    • Table Bristol-Myers Squibb Co (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Co Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Co Blood Pressure Disorders Drug Product and Service

    • Table BioRestorative Therapies Inc (Foundation Year, Company Profile and etc.)

    • Table BioRestorative Therapies Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioRestorative Therapies Inc Blood Pressure Disorders Drug Product and Service

    • Table Acceleron Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Acceleron Pharma Inc Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acceleron Pharma Inc Blood Pressure Disorders Drug Product and Service

    • Table Chong Kun Dang Pharmaceutical Corp (Foundation Year, Company Profile and etc.)

    • Table Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US